Concepedia

David W. Bedwell

DW

Statistics

Publications

8

Citations

322

H-Index

8

Active since

2000

Affiliations

Eli Lilly (United States)(Current)

David W. Bedwell is an author at Eli Lilly (United States) specializing in pharmacokinetics, pharmacology, and drug disposition.

Publications per year

2000–2018

8

Publications

8

Ablation of Both Organic Cation Transporter (Oct)1 and Oct2 Alters Metformin Pharmacokinetics but Has No Effect on Tissue Drug Exposure and Pharmacodynamics

J. William Higgins, David W. Bedwell, Maciej J. Zamek‐Gliszczynski · Drug Metabolism and Disposition · 2012 · 109 citations

, , +17

Characterization of SAGE Mdr1a (P-gp), Bcrp, and Mrp2 Knockout Rats Using Loperamide, Paclitaxel, Sulfasalazine, and Carboxydichlorofluorescein Pharmacokinetics

Maciej J. Zamek‐Gliszczynski, David W. Bedwell, Jing Bao et al. · Drug Metabolism and Disposition · 2012 · 91 citations

, , +13

Difference in the Pharmacokinetics and Hepatic Metabolism of Antidiabetic Drugs in Zucker Diabetic Fatty and Sprague-Dawley Rats

Xin Zhou, L. Rougée, David W. Bedwell et al. · Drug Metabolism and Disposition · 2016 · 28 citations · Full text

, , +17

The Impact of the Hepatocyte-to-Plasma pH Gradient on the Prediction of Hepatic Clearance and Drug-Drug Interactions for CYP2D6 Substrates

L. R. A. Rougee, Michael A. Mohutsky, David W. Bedwell et al. · Drug Metabolism and Disposition · 2016 · 25 citations

, , +17

Elimination of Matrix-Based Interferences to a Fluorescent Nitrite/Nitrate Assay by a Simple Filtration Procedure

David W. Bedwell, Victor R. Rivera, Gerald A. Merrill et al. · Analytical Biochemistry · 2000 · 19 citations

, , +9

1–5 of 8